Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by jfm1330


T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:Sortilin info

In Dr. Beauregard profile you can read this: Another strategy we are...

April 18, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:Sortilin info

It is sure that they don't disclose every research things that they try...

April 18, 2022

T.TH

RE:RE:RE:RE:RE:RE:Sortilin info

After further readings, cells tested by immunostaining are permeabilized...

April 17, 2022

T.TH

RE:RE:RE:RE:Sortilin info

About the 90/10 sortilin distribution, I was aking the question to know if...

April 17, 2022

T.TH

RE:Sortilin info

If you look closely you will see they use two types of antibodies for...

April 16, 2022

T.TH

Marsolais will speak at Novel Format Conjugates Summit

Register now! We are proud to announce that Christian Marsolais will be a...

April 15, 2022

T.TH

RE:Amendment to trial design

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677113/

April 15, 2022

T.TH

RE:Some Additional Random Thoughts

The problem with NASH is not the science behind tesamorelin in this...

April 14, 2022

T.TH

RE:RE:RE:RE:RE:RE:Quick Summary

To put it in a nutshell, I was very annoyed to hear them talking about TH1902...

April 13, 2022

T.TH

RE:RE:RE:RE:Cash position

That's a lot of hinting don't you think? And again, you can see what...

April 13, 2022

T.TH

RE:RE:Quick Summary

Highly frustrated with the answer from Marsolais when asked to corrolate what...

April 13, 2022

T.TH

RE:RE:Theratechnologies is a Buy, says Research Capital

Don't confuse starting with one cancer type in phase II and fast track...

April 12, 2022

T.TH

RE:RE:RE:RE:BCYC down 33% pre market

Personally, out of this phase Ia, I am interested in strong indications that...

April 11, 2022

T.TH

Mechanisms of action

This phase Ia is so long that I forgot some of the stuff that I wrote here...

April 9, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:New PR

It would be strange to have this PR out with positive comments by Marsolais...

April 8, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:So anything good coming out soon

We will never agree on the stock promotion and investors relations. I just...

April 7, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:So anything good coming out soon

Levesque pushed the NASH narrative very hard and needed to subtly backpedal...

April 7, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:So anything good coming out soon

Funny to see how things can change, former CEO was lambasted here when he was...

April 6, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:So anything good coming out soon

In french we say: "avec des si on mettrait Paris en bouteille."...

April 5, 2022

T.TH

RE:RE:RE:RE:RE:RE:So anything good coming out soon

They have three PDCs in human clinical trials, one in phase II, and they have...

April 5, 2022

Featured Company